Abstract
A primary anti-coagulant narrow therapeutic index warfarin sodium poses a high risk of thrombosis or excessive bleeding with a sudden death. The root cause for these risks are not well established....
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
